| answer text |
<p>The 36 month pre-exposure prophylaxis (PrEP) Impact Trial is scheduled to continue
until autumn 2020. Work is now starting to consider future commissioning for PrEP
after the Trial has ended, which includes consideration of funding options.</p><p>The
PrEP Impact trial is managed by the Trial Sponsor. Recruitment to places in the Trial
is managed locally by participating clinics. Information on why the Gate Clinic at
Kent and Canterbury Hospital is not open to gay and bisexual men is not held centrally.</p><p>Following
funding from NHS England to pay for extra PrEP drug and research costs and the Secretary
of State’s announcement on 30 January that the number of places on the PrEP Impact
Trial would be doubled to 26,000, expansion of the Trial is now underway across the
country. Participation in the Trial is on a voluntary basis and it is for research
clinics and local authorities to decide whether they wish to take part and the number
of allocated places they can accept.</p>
|
 |
